540395 — Chemcrux Enterprises Income Statement

0.000.00%

Last trade - 00:00

HealthcareAdventurousMicro CapFalling Star

Annual income statement for Chemcrux Enterprises, fiscal year end - March 31st, INR millions except per share, conversion factor applied.

	R2022 March 31st	2023 March 31st	2024 March 31st	2025 March 31st	2026 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IAS	IAS	IAS	IAS	—
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	953	952	785	700	806
Cost of Revenue
Gross Profit	474	522	390	346	481
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	762	757	674	640	742
Operating Profit	191	194	111	60.2	64
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	199	196	114	57.7	52.8
Provision for Income Taxes
Net Income After Taxes	149	144	84.4	39.2	37.3
Equity in Affiliates
Net Income Before Extraordinary Items
Net Income	149	144	84.4	39.1	37.3
Adjustments to Net Income
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	149	144	84.4	39.1	37.3
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	10	9.69	5.79	2.61	2.52
Dividends per Share